Re-expression of epigenetically silenced PTPRR by histone acetylation sensitizes RAS-mutant lung adenocarcinoma to SHP2 inhibition-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Re-expression of epigenetically silenced PTPRR by histone acetylation sensitizes RAS-mutant lung adenocarcinoma to SHP2 inhibition

Published:2024-01-28 Issue:1 Volume:81 Page:
ISSN:1420-682X
Container-title:Cellular and Molecular Life Sciences
language:en
Short-container-title:Cell. Mol. Life Sci.

Author:

Du Tingting,Hu Xiaowen,Hou Zhenyan,Wang Weida,You Shen,Wang Mingjin,Ji Ming,Xue Nina,Chen Xiaoguang^ORCID

Funder

National Natural Science Foundation of China

CAMS Innovation Fund for Medical Sciences

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00018-023-05034-w.pdf

Reference36 articles.

1. Zheng R, Zhang S, Wang S et al (2022) Lung cancer incidence and mortality in China: updated statistics and an overview of temporal trends from 2000 to 2016. J Nat Cancer Cent 2:139–147

2. Prior IA, Lewis PD, Mattos C (2012) A comprehensive survey of Ras mutations in cancer. Cancer Res 72:2457–2467

3. Simanshu DK, Nissley DV, McCormick F (2017) RAS proteins and their regulators in human disease. Cell 170:17–33

4. Network CGAR (2018) Comprehensive molecular profiling of lung adenocarcinoma. Nature 511:543

5. Huang L, Guo Z, Wang F et al (2021) KRAS mutation: from undruggable to druggable in cancer. Signal Transduct Target Ther 6:386

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP